Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00489723|
Recruitment Status : Unknown
Verified June 2007 by HaEmek Medical Center, Israel.
Recruitment status was: Recruiting
First Posted : June 21, 2007
Last Update Posted : June 21, 2007
The purpose of this study is to determine if there is a role of prophylactic therapy with tamsulosin prior extracorporeal shock wave lithotripsy to avoid development of steinstrasse. 150 persons that will go to Extracorporeal shock wave lithotripsy will randomize to 2 groups.
Group 1 -of 75 persons will recieve tamsulosin 0.4 mg x 1/d 2 days before the lithotripsy .
Group 2 - of 75 persons will not recieve tamsulosin. 48 hour after the ESWL all 2 group will take abdominal radiograph to evaluate the presence of steinstrasse.
|Condition or disease||Intervention/treatment|
|Kidney Stones||Drug: tamsulosin 0.4mg|
|Study Type :||Observational|
|Observational Model:||Defined Population|
|Study Start Date :||May 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00489723
|Contact: DORON PEREZ, M.D.||+firstname.lastname@example.org|
|Haemek medical center||Recruiting|
|Afula, Israel, 18100|
|Contact: DORON PEREZ, M.D. +972-4-6495115 email@example.com|
|Principal Investigator: doron perez, M.D.|
|Principal Investigator:||doron perez||Urology department: Haemek Medical Center|